Interestingly, the Enriched Drug Families table of this query highlighted Statins (p-value < 0.01) and Imatinib analogues (p-value < 0.01) as the only two classes of drugs significantly associated to drug sensitivity in cancer cell lines harbouring NF2 mutations (Supplementary Figure 1). The gene discussed is NF2; the disease is cancer.